先进影像设备
Search documents
跟医院达成10年合作!GE医疗助力影像能力升级
思宇MedTech· 2026-02-27 06:37
2026年2月27日,GE医疗GE HealthCare 宣布与美国知名医院 UCSF Health 达成一项 为期10年的 Care Alliance 合作协议。 该合作将推动先进影像设备部署、远程扫描支持及影像技术人才培养,旨在全面提升 医疗服务效率与可及性。 UCSF Health隶属于 加州大学旧金山分校 ,是美国顶尖的学术医疗体系之一。类似中国的 大型三甲医 院与医学中心 ,既承担疑难重症诊疗任务,又负责医学教育与前沿科研转化。该体系在神经科学、肿瘤 学、影像医学及复杂疾病治疗等领域具有全球影响力,同时也是新技术临床验证与医疗模式创新的重要 平台。 这是一种正在加速普及的合作模式: 医疗器械厂商,成为医院长期运营与技术合作伙伴。 # 合作内容:从设备部署走向系统能力建设 根据双方披露的信息,此次合作重点包括: 1. 影像能力升级 2. 远程影像与可及性提升 3. 人才与技术能力建设 放射技师培训与沉浸式实践 在多个医疗场景部署先进影像系统 优化MRI性能与检查流程 提升诊断一致性与效率 推进远程扫描支持(remote scanning support) 降低服务可及性障碍 支持社区与基层医疗覆盖 4 ...
GE医疗与阿里达摩院签约 共同探索推动“一扫多查”医疗AI
Yang Guang Wang· 2025-11-06 10:08
Core Insights - GE Healthcare and Alibaba DAMO Academy signed a cooperation framework agreement to integrate DAMO's "One Scan, Multiple Checks" AI technology into GE's advanced imaging equipment, aiming to create an intelligent and precise diagnosis solution [1][2] - This partnership marks the first collaboration between DAMO Academy and a medical device manufacturer, indicating a significant step towards the large-scale application of their AI technology [1] - DAMO Academy has made breakthroughs in AI screening for major diseases such as pancreatic cancer and aortic dissection, with their results published in top medical journals and recognized by the FDA as a "breakthrough medical device" [1] Company and Industry Summary - GE Healthcare aims to leverage its long-standing expertise in high-end medical equipment manufacturing and digital solutions, combined with DAMO's leading AI capabilities, to enhance diagnostic accuracy and efficiency, particularly for hard-to-detect diseases [2] - The collaboration will focus on optimizing models and innovating methods, with the goal of productizing their technological solutions [2] - GE Healthcare's CTO emphasized the integration of AI into the entire imaging process, aiming to transform medical imaging towards a deep learning AI era [2] - DAMO Academy's director highlighted the importance of medical imaging as a key area for AI innovation in healthcare, expressing the desire to accelerate the integration of AI with high-end medical devices [2]
聚焦上海两大先导产业 《先锋企业创新力年度报告 2025》发掘硬科技“未来之星”
Sou Hu Cai Jing· 2025-09-25 06:13
Core Insights - The report highlights the emergence of "pioneer enterprises" in Shanghai's biotechnology and artificial intelligence sectors, focusing on startups with high growth potential driven by technological innovation [1][2]. Biotechnology Sector - A total of 63 pioneer growth enterprises were identified in Shanghai's biotechnology field, spanning various sub-sectors such as medical R&D outsourcing, medical devices, cell therapy, gene therapy, digital healthcare, raw materials, chemical drugs, biological drugs, consumables, and IVD (in vitro diagnostics) [2]. - The majority of these enterprises are concentrated in Zhangjiang High-tech Park, accounting for nearly 90% of the total [2]. - In terms of revenue, the chemical drug sector leads with an average revenue of 32 million yuan, followed by cell therapy and medical R&D outsourcing, both exceeding 20 million yuan in average revenue [2]. - The medical service, IVD, biological drug, and gene therapy sectors show a mid-high revenue range, with average revenues between 16 million and 13 million yuan [2]. Artificial Intelligence Sector - The report identified 49 pioneer growth enterprises in Shanghai's artificial intelligence sector, covering areas such as entertainment consumption, data, automotive, industrial, logistics, large models, asset management, education, fintech, and robotics [2]. - Similar to the biotechnology sector, enterprises in the Pudong New Area dominate, although their leading advantage has diminished due to limited concentration in Zhangjiang Science City [2]. Pioneer Enterprises Evaluation - Based on the "Pioneer Growth Enterprise Database," the top ten performing enterprises in the biotechnology and artificial intelligence sectors were designated as pioneer enterprises [3]. - In the biotechnology sector, the medical R&D outsourcing cluster shows significant advantages, with animal testing platforms becoming a popular area, while advanced imaging equipment manufacturers and innovative pharmaceutical companies stand out [3]. - In the artificial intelligence sector, pioneer enterprises are actively engaging in key areas such as multimodal large models, underlying technologies for autonomous driving, and the integration of "future industries + AI" [3]. - Pioneer enterprises are viewed as crucial for driving original innovations and industrial transformations, contributing to a more open and internationally influential innovation ecosystem [3].